Boosters

New Study Shows Millions Saved by COVID Vaccination

COVID-19 vaccination saved an estimated 2.5 million lives, according to a new modeling study published in JAMA ...

AUGUST 4, 2025

Bivalent Boosters Protect Against New COVID-19 Variants

Bivalent, mRNA, COVID-19 booster vaccines provide protection against omicron XBB-related SARS-CoV-2 lineages, ...

MARCH 2, 2023

CDC Urges Need for Boosters, COVID-19 Action Plan for Immunocompromised

With monoclonal antibodies lacking efficacy, the CDC urged all people, especially those who are immunocompromised, ...

FEBRUARY 13, 2023

Bivalent COVID-19 Booster Essential for Older Adults, Even as Cases Decline

Staying up-to-date with bivalent COVID-19 boosters is essential to protect older adults against severe disease, ...

JANUARY 25, 2023

FDA Authorizes Moderna’s and Pfizer’s Bivalent COVID-19 Vaccines for Boosters in Children Ages 5+

The FDA amended the emergency use authorizations of both the Moderna and Pfizer-BioNTech bivalent COVID-19 vaccines ...

OCTOBER 12, 2022

Ensuring a Protective Cocoon Around Immunocompromised Adults

Immunizing before a patient has been immunosuppressed is the best approach. For patients who are already ...

OCTOBER 12, 2022

mRNA Booster Protection Wanes Over Time, Supporting the Need for Additional Boosters

Protection from SARS-CoV-2 is extended with a messenger RNA (mRNA) booster. But that defense wanes over time, ...

OCTOBER 5, 2022

Efficacy of COVID-19 Vaccines Against Omicron Shows Benefit of Boosters

The effectiveness of the COVID-19 vaccines currently available in the United States is less against omicron than ...

AUGUST 4, 2022

FDA Recommends Omicron, Bivalent COVID-19 Boosters for Fall

The FDA has now recommended the addition of an omicron BA.4/5 component in COVID-19 vaccine booster doses.

JULY 5, 2022

Mixing and Matching COVID Vaccines and Boosters May Bolster Protection

Increased COVID-19 vaccine performance may be the result of mixing and matching different types of vaccines and ...

MAY 17, 2022

FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to 5 Months

Omicron is the reason for the shortening the time between primary series and booster doses, FDA says.

JANUARY 7, 2022

FDA Expands EUAs for Moderna, J&J COVID-19 Boosters

The FDA expanded its EUAs for the Moderna and J&J COVID-19 vaccines to allow booster doses for eligible ...

OCTOBER 21, 2021

Load more